Senores Pharmaceuticals Ltd Stock News

Senores Pharmaceuticals Ltd Share Price
Detail Overview
Pharmaceuticals - Indian - FormulationsNSE
₹1,215.30
+12.70(+1.06%)
As on 23 Oct 2026 at 15:59
As of 23 Oct 2026 at 15:59, Senores Pharmaceuticals Ltd is trading at ₹1,215.30. The 52-week range stands at ₹706.00–₹1,599.00, with a market cap of ₹5.59 thousand crore. At a P/E of 300.47 and a dividend yield of 0.00%, it is a mid-cap stock in the Pharmaceuticals sector.

SENORES Price Chart

Market Cap
₹5.59K Cr
PE Ratio
300.47
ROCE
4.12%

Senores Pharmaceuticals Ltd Latest News

View More
13 OCT 2026 | Tuesday
Senores Pharmaceuticals re-appoints Swapnil Shah as Managing Director for three years
13 OCT 2026 | Tuesday
Senores Pharmaceuticals re-appoints Swapnil Shah and Chetan Shah for three years
08 OCT 2026 | Thursday
Senores Pharmaceuticals confirms regulatory compliance for quarter ended September 30, 2026
24 SEPT 2026 | Thursday
Senores Pharmaceuticals will restrict trading for insiders during financial results announcement period
26 AUG 2026 | Wednesday
Senores Pharmaceuticals expands internationally with subsidiaries in Mexico and Canada
26 AUG 2026 | Wednesday
Senores Pharmaceuticals to establish subsidiaries in Mexico and Canada for distribution
26 AUG 2026 | Wednesday
Senores Pharmaceuticals appoints Dr. Shah as Director and approves ESOS 2026 for employees
26 AUG 2026 | Wednesday
Senores Pharmaceuticals appoints Dr. Shah, plans subsidiaries in Mexico and Canada
26 AUG 2026 | Wednesday
Senores Pharmaceuticals to establish subsidiaries in Mexico and Canada for market expansion
22 JUL 2026 | Wednesday
Senores Pharmaceuticals to table results

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now